# Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

> **NCT01175083** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 300 (actual)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** GSK1024850A (Synflorix)
- **BIOLOGICAL:** Tritanrix-HepB/Hib
- **BIOLOGICAL:** Polio Sabin

## Key facts

- **NCT ID:** NCT01175083
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-01
- **Primary completion:** 2013-01-17
- **Final completion:** 2013-05-23
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175083, "Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01175083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*